FDA indicators scarcity of neurosurgical pads and sponges, expects disruption till 2026 – The Journal of Healthcare Contracting

FDA indicators scarcity of neurosurgical pads and sponges, expects disruption till 2026 – The Journal of Healthcare Contracting

Might 8, 2026 – The U.S. Meals and Drug Administration (FDA) on Wednesday acknowledged ongoing provide disruptions of neurosurgical patties, sponges and strips, warning that the scarcity might final till the top of 2026.

In March, Medline Industries recalled neurosurgical patties in its neurosponge line because of elevated endotoxin ranges, and not using a return date set, the FDA mentioned.

Healthcare supplier Premier mentioned the recalled merchandise are extremely specialised for mind and backbone surgical procedure. “This can be a low-frequency, high-risk product,” mentioned Karen Niven, senior director of medical worth evaluation at Premier. “We’ve got suggested our members to have a look at conservation first.”

The FDA mentioned it’s working with different producers and healthcare suppliers to watch provides and consider methods to cut back the affect on sufferers.

Proceed studying

Leave a Reply

Your email address will not be published. Required fields are marked *